UBS Group’s DTRT Health Acquisition Corp. Class A Common Stock DTRT Stock Holding History

UBS Group’s Portfolio DTRT Stock Details DTRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,860	Closed	-$19.3K	–	11436
2022 Q4	$19.3K	Buy	1,860 +940	+102%	+$9.63K	﹤0.01%	7687
2022 Q3	$9K	Sell	920 -7,768	-89%	-$78.6K	﹤0.01%	8662
2022 Q2	$87K	Buy	8,688 +8,185	+1,627%	+$82.2K	﹤0.01%	5535
2022 Q1	$5K	Buy	503 +280	+126%	+$2.8K	﹤0.01%	9231
2021 Q4	$2K	Buy	+223	New	+$2.22K	﹤0.01%	9902

UBS Group's DTRT Position: Q1 2023 in Review

UBS Group sold out of DTRT Health Acquisition Corp. Class A Common Stock (DTRT) in Q1 2023, closing a stake of 1,860 shares — an estimated $19.3K sold.

UBS Group first reported a position in DTRT in Q4 2021 and held it in 5 quarters. The position peaked at $87K in Q2 2022. 0 funds tracked by Wall St. Rank hold DTRT as of Q1 2023.

UBS Group reported no remaining DTRT Health Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
UBS Group sold 1,860 DTRT Health Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $19.3K.
UBS Group first reported a position in DTRT Health Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 5 quarters.
UBS Group's DTRT Health Acquisition Corp. Class A Common Stock position peaked at $87K in Q2 2022.
0 funds tracked by Wall St. Rank held DTRT Health Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.